Loading…

Medical Research Finder

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

Adoptive T Cell Therapy / CAR-T & Hodgkin Lymphoma

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

Adoptive T Cell Therapy / CAR-T in Hodgkin lymphoma is an active research area, but CAR-T is still not a standard approved therapy for classical Hodgkin lymphoma (cHL). The most clinically advanced approach is CD30 CAR-T & Hodgkin Lymphoma
Ho et al. 2021 Blood Adv. 5(20): 4291-4302
Braun et al. 2025 Leukemia 39: 1337-1341

…

Adoptive T-cell therapy for Hodgkin lymphoma
Ho et al. 2021 Blood Adv. 5(20): 4291-4302
Review
Anti-CD30 CAR-T Cell Therapy in Relapsed and Refractory Hodgkin Lymphoma
Ramos et al. 2020 JCO 38: 3794–3804
Emerging T-cell lymphomas after CAR T-cell therapy
Braun et al. 2025 Leukemia 39: 1337-1341
Steering Chimeric Antigen Receptor T Cells Into the Hodgkin Lymphoma Niche
Bröckelmann et al. 2020 JCO 38: 3816-3818

7/1/2026